| CTCF | A549 (lung carcinoma) | 1 h with 100 nM Dexamethasone (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000AUE | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 1 h with 0.02% Ethanol (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000AUF | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 1 h with 100 nM Dexamethasone (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BHV | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 1 h with 0.02% Ethanol (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BHW | MA0139.1 | 
  
    
    | CTCF | SK-N-SH (neuroblastoma) | 6 μM all-trans-retinoic acid (CHEBI:15367) for 48 hour | Permissive
      
      Robust | Homo sapiens | ENCSR000BLX | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | 1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BNO | MA0139.1 | 
  
    
    | CTCF | Ishikawa (endometrial adenocarcinoma) | 1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BQE | MA0139.1 | 
  
    
    | CTCF | LNCaP clone FGC | 12 hrs with 1 nM Methyltrienolone (R1881) (Crawford) | Permissive
      
      Robust | Homo sapiens | ENCSR000DME | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | 45 min with 100 nM Estradiol (Crawford) | Permissive
      
      Robust | Homo sapiens | ENCSR000DMS | MA0139.1 | 
  
    
    | CTCF | SK-N-SH (neuroblastoma) | 6 μM all-trans-retinoic acid (CHEBI:15367) for 48 hour | Permissive
      
      Robust | Homo sapiens | ENCSR000DXQ | MA0139.1 | 
  
    
    | CTCF | LNCaP (prostate carcinoma) | 10 nM 17β-hydroxy-5α-androstan-3-one (CHEBI:16330) for 4 hour | Permissive
      
      Robust | Homo sapiens | ENCSR673WZL | MA0139.1 | 
  
    
    | CTCF | bipolar neuron | 0.5 μg/mL doxycycline hyclate (CHEBI:34730) for 4 day | Permissive
      
      Robust | Homo sapiens | ENCSR066BZZ | MA0139.1 | 
  
    
    | CTCF | 22RV1 (prostate carcinoma) | 10 nM 17β-hydroxy-5α-androstan-3-one (CHEBI:16330) for 4 hour | Permissive
      
      Robust | Homo sapiens | ENCSR847XGE | MA0139.1 | 
  
    
    | CTCF | foreskin keratinocyte | 1mM calcium (CHEBI:86158) for 5 day | Permissive
      
      Robust | Homo sapiens | ENCSR812FNU | MA0139.1 | 
  
    
    | CTCF | foreskin keratinocyte | 1mM calcium (CHEBI:86158) for 2 day | Permissive
      
      Robust | Homo sapiens | ENCSR036EGV | MA0139.1 | 
  
    
    | CTCF | whole organism (development stage: embryonic) | strain: CTCF-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CTCF-GFP.FPTB}attP40, sex:mixed | Permissive
      
      Robust | Drosophila melanogaster | ENCSR661BEZ | MA0531.1 | 
  
    
    | CTCF | embryonic stem cells | Dnmt1/3a/3b KO | Permissive
      
      Robust | Mus musculus | GSE30203
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells | RAG1 KO | Permissive
      
      Robust | Mus musculus | GSE21978
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD36+ erythroid cells | BRG1 KD shLuc control | Permissive
      
      Robust | Homo sapiens | GSE26501
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD36+ erythroid cells | BRG1 RNAi KD | Permissive
      
      Robust | Homo sapiens | GSE26501
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G1E-ER4 (embryonic stem cells) | 24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison) | Permissive
      
      Robust | Mus musculus | ENCSR000DIR
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MEL cell line | 5 d with 2% Dimethyl sufloxide (DMSO) (Weissman) | Permissive
      
      Robust | Mus musculus | ENCSR000ETE
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | B-cells | stimulated | Permissive
      
      Robust | Mus musculus | GSE43594
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | oestrogen, CTCF siRNA | Permissive
      
      Robust | Homo sapiens | GSE25021
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | oestrogen | Permissive
      
      Robust | Homo sapiens | GSE25021
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | oestrogen | Permissive
      
      Robust | Homo sapiens | GSE25021
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) | none | Permissive
      
      Robust | Homo sapiens | GSE25021
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | dendritic cells | LPS, 0 min | Permissive
      
      Robust | Mus musculus | GSE36099
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | dendritic cells | LPS, 120 min | Permissive
      
      Robust | Mus musculus | GSE36099
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | dendritic cells | LPS, 30 min | Permissive
      
      Robust | Mus musculus | GSE36099
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | dendritic cells | LPS, 60 min | Permissive
      
      Robust | Mus musculus | GSE36099
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD34+ hematopoietic stem cells-derived proerythroblasts | 2-trimester fetal liver | Permissive
      
      Robust | Homo sapiens | GSE36985
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD34+ hematopoietic stem cells-derived proerythroblasts | adult bone marrow | Permissive | Homo sapiens | GSE36985
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) | DNMT1KO | Permissive
      
      Robust | Homo sapiens | GSE50610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) | DNMT3BKO | Permissive
      
      Robust | Homo sapiens | GSE50610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) | No special treatment | Permissive
      
      Robust | Homo sapiens | GSE50610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) | DNMT1KO, DNMT3BKO | Permissive
      
      Robust | Homo sapiens | GSE50610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) | 5-aza-2’-deoxycytidine (decitabine; Sigma, A3656) dissolved in DMSO to 10mM. Drug was administered at 1uM daily for 3 days. Control K562 cells were mock treated with DMSO. | Permissive
      
      Robust | Homo sapiens | GSE50610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) | none | Permissive
      
      Robust | Homo sapiens | GSE50611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | erythroid progenitors | none | Permissive
      
      Robust | Homo sapiens | GSE52637
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | unstimulated | Permissive
      
      Robust | Homo sapiens | GSE53463
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | progestin R5020-stimulated | Permissive
      
      Robust | Homo sapiens | GSE53463
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | BEAS-2B (bronchial epithelium) | NiCl2 | Permissive
      
      Robust | Homo sapiens | GSE56051
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver | Taf4-/- | Permissive
      
      Robust | Mus musculus | GSE57807
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Th1-cells | FACS sorted naive CD4+T cells cultured in vitro for 7 days under Th1 condition | Permissive
      
      Robust | Mus musculus | GSE60482
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WEHI-231 (lymphoma ) | TFII-I KD | Permissive
      
      Robust | Mus musculus | GSE60917
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 brain-derived neural progenitor cells | Smchd1 null | Permissive
      
      Robust | Mus musculus | GSE65748
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 brain-derived neural progenitor cells | non-silencing shRNA | Permissive
      
      Robust | Mus musculus | GSE65748
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | dermal fibroblasts | Xist deletion | Permissive
      
      Robust | Mus musculus | GSE67516
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts | AKT1 KO | Permissive
      
      Robust | Mus musculus | GSE69798
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 226LDM (normal breast luminal cells) | untreated | Permissive
      
      Robust | Homo sapiens | GSE102237
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 226LDM (normal breast luminal cells) | hydroxyurea and nocodazole | Permissive
      
      Robust | Homo sapiens | GSE102237
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brown preadipocytes | Pparg-flox/flox | Permissive
      
      Robust | Mus musculus | GSE74189
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brown preadipocytes | Pparg-flox/flox | Permissive
      
      Robust | Mus musculus | GSE74189
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brown preadipocytes | Pparg-flox/flox | Permissive
      
      Robust | Mus musculus | GSE74189
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brown adipocytes | Pparg-flox/flox | Permissive
      
      Robust | Mus musculus | GSE74189
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | WT; 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | WT; 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | Ctcf(fl/fl); 4h Adeno-Cre and 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | Rosa26(CreER/+) Smc3(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | Rosa26(CreER/+) Smc3(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | Rosa26(CreER/+) Wapl(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 embryonic fibroblasts | Rosa26(CreER/+) Wapl(fl/-); 2-3d 4'hydroxytamoxifen and 10d resting | Permissive
      
      Robust | Mus musculus | GSE76303
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G1E-derived erythroid cells | D_Brd2KO | Permissive
      
      Robust | Mus musculus | GSE80527
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G1E-derived erythroid cells | C8_Brd2KO | Permissive
      
      Robust | Mus musculus | GSE80527
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen B-cells | activated | Permissive
      
      Robust | Mus musculus | GSE82144
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen B-cells | resting | Permissive
      
      Robust | Mus musculus | GSE82144
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | epidermal keratinocytes | undifferentiated | Permissive
      
      Robust | Homo sapiens | GSE84657
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | epidermal keratinocytes | day3 of differentiation | Permissive
      
      Robust | Homo sapiens | GSE84657
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | epidermal keratinocytes | day6 of differentiation | Permissive
      
      Robust | Homo sapiens | GSE84657
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | control; 100 nM 17-beta-estradiol for 0h | Permissive
      
      Robust | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | 100 nM 17-beta-estradiol for 45 min | Permissive
      
      Robust | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | 100 nM 17-beta-estradiol for 3h | Permissive | Homo sapiens | GSE85106
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | V6.5 (embryonic stem cells) | 2i/LIF conditions | Permissive
      
      Robust | Mus musculus | GSE85185
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | V6.5 (embryonic stem cells) | standard serum/LIF conditions | Permissive
      
      Robust | Mus musculus | GSE85185
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | retina | p107 minus minus MDMXTg | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD4+ Th1 | high IL-2 | Permissive
      
      Robust | Mus musculus | GSE88857
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD4+ Th1 | low IL-2 | Permissive
      
      Robust | Mus musculus | GSE88857
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD4+ Th1 | low IL-2 + aKG | Permissive
      
      Robust | Mus musculus | GSE88857
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | JM8.N4 (embryonic stem cells) | Rad21-SNAPf-V5 | Permissive
      
      Robust | Mus musculus | GSE90994
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delAB mutant | Permissive
      
      Robust | Mus musculus | GSE92587
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delC mutant | Permissive
      
      Robust | Mus musculus | GSE92587
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delE mutant | Permissive
      
      Robust | Mus musculus | GSE92587
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delCDE mutant | Permissive
      
      Robust | Mus musculus | GSE92587
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delD mutant | Permissive
      
      Robust | Mus musculus | GSE92587
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delA mutant | Permissive
      
      Robust | Mus musculus | GSE92591
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delC mutant | Permissive
      
      Robust | Mus musculus | GSE92591
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delB mutant | Permissive
      
      Robust | Mus musculus | GSE92591
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland | delD mutant | Permissive
      
      Robust | Mus musculus | GSE92591
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) | +DOX 3 days, mutant CTCF | Permissive
      
      Robust | Homo sapiens | GSE92879
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver | tamoxifen | Permissive
      
      Robust | Mus musculus | GSE93431
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver | tamoxifen | Permissive
      
      Robust | Mus musculus | GSE93431
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen-derived Ter119+ erythroid cells | Phenylhydrazine | Permissive
      
      Robust | Mus musculus | GSE97869
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen-derived Ter119+ erythroid cells | D29 mutant of CTCF; Phenylhydrazine | Permissive
      
      Robust | Mus musculus | GSE97869
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen-derived Ter119+ erythroid cells | D38_D39 mutant of CTCF; Phenylhydrazine | Permissive
      
      Robust | Mus musculus | GSE97869
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen-derived Ter119+ erythroid cells | D38 mutant of CTCF; Phenylhydrazine | Permissive
      
      Robust | Mus musculus | GSE97869
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen-derived Ter119+ erythroid cells | D39 mutant of CTCF; Phenylhydrazine | Permissive
      
      Robust | Mus musculus | GSE97869
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) | washoff2days | Permissive
      
      Robust | Mus musculus | GSE98671
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex | CK-KO | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex | CK-KO | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex | CK-KO | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex | CK-KO | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 3 hour | Permissive
      
      Robust | Homo sapiens | ENCSR851SOK | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 6 hour | Permissive
      
      Robust | Homo sapiens | ENCSR287UXS | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 4 hour | Permissive
      
      Robust | Homo sapiens | ENCSR130TQM | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 1 h with 100 nM Dexamethasone (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR249JOH | MA0139.1 | 
  
    
    | CTCF | bipolar neuron | 0.5 μg/mL doxycycline hyclate (CHEBI:34730) for 4 day | Permissive
      
      Robust | Homo sapiens | ENCSR619IUE | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 10 hour | Permissive
      
      Robust | Homo sapiens | ENCSR336VBV | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 30 minute | Permissive
      
      Robust | Homo sapiens | ENCSR553UWG | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 7 hour | Permissive
      
      Robust | Homo sapiens | ENCSR173IEA | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 8 hour | Permissive
      
      Robust | Homo sapiens | ENCSR432AXE | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 2 hour | Permissive
      
      Robust | Homo sapiens | ENCSR384KPP | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 12 hour | Permissive
      
      Robust | Homo sapiens | ENCSR414CQB | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 5 hour | Permissive
      
      Robust | Homo sapiens | ENCSR876UZD | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | thrombopoietin 30 minutes | Permissive
      
      Robust | Mus musculus | GSE100835
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | serum-starved | Permissive
      
      Robust | Mus musculus | GSE100835
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic distal forelimb | CD1 strain | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic proximal forelimbs | CD1 strain | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic forelimbs and hindlimbs | B6CBAF1 strain | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic forelimbs and hindlimbs | B6CBAF1 strain; delHoxd(8-13)d11lac | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic forelimbs and hindlimbs | B6CBAF1 strain; delHoxd(8-13)rXII | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic forelimbs and hindlimbs | B6CBAF1 strain; delHoxd(1-13)d9lac | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic forelimbs and hindlimbs | B6CBAF1 strain; delHoxd(attP-rel5)d9lac | Permissive
      
      Robust | Mus musculus | GSE101714
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD34+ stem cells-derived erythroblasts | Fetal | Permissive
      
      Robust | Homo sapiens | GSE102184
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD34+ stem cells-derived erythroblasts | Adult | Permissive
      
      Robust | Homo sapiens | GSE102184
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa Kyoto (cervical adenocarcinoma) | Wild type | Permissive
      
      Robust | Homo sapiens | GSE102884
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa Kyoto (cervical adenocarcinoma) | Wapl-depletion | Permissive
      
      Robust | Homo sapiens | GSE102884
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa Kyoto (cervical adenocarcinoma) | Pds5SA/B depletion | Permissive
      
      Robust | Homo sapiens | GSE102884
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa Kyoto (cervical adenocarcinoma) | Wapl/Pds5A/B depletion | Permissive
      
      Robust | Homo sapiens | GSE102884
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver | ZT22 (5AM); Wild type | Permissive
      
      Robust | Mus musculus | GSE104129
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver | ZT10 (5PM); Wild type | Permissive
      
      Robust | Mus musculus | GSE104129
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts | Firre KO | Permissive
      
      Robust | Mus musculus | GSE104427
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts | Firre transgene | Permissive
      
      Robust | Mus musculus | GSE104427
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116-RAD21-mAC | 500uM auxin (360 min) | Permissive
      
      Robust | Homo sapiens | GSE104888
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow-derived macrophages | C57BL/6; 3 months; male | Permissive
      
      Robust | Mus musculus | GSE107455
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | S2-DRSC (embryonic stem cells) | strain: Oregon-R, genotype: wild type | Permissive
      
      Robust | Drosophila melanogaster | ENCSR711UTK | MA0531.1 | 
  
    
    | CTCF | S2-DRSC (embryonic stem cells) | strain: Oregon-R, genotype: wild type | Permissive
      
      Robust | Drosophila melanogaster | ENCSR918GXT | MA0531.1 | 
  
    
    | CTCF | whole organism (development stage: prepupa) | white prepupae stage | Permissive
      
      Robust | Drosophila melanogaster | GSE24449
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | 20-HE 0 hrs | Permissive
      
      Robust | Drosophila melanogaster | GSE30740
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | 20-HE 3 hrs | Permissive
      
      Robust | Drosophila melanogaster | GSE30740
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | 20-HE 48 hrs | Permissive
      
      Robust | Drosophila melanogaster | GSE30740
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | Interphase | Permissive
      
      Robust | Drosophila melanogaster | GSE32584
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | Mitosis | Permissive
      
      Robust | Drosophila melanogaster | GSE32584
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | S2-DRSC (embryonic stem cells) | 3AB treated | Permissive
      
      Robust | Drosophila melanogaster | GSE41354
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | 5-13 h embryo | parasegment 7 | Permissive
      
      Robust | Drosophila melanogaster | GSE55257
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | 5-13 h embryo | whole embryo | Permissive
      
      Robust | Drosophila melanogaster | GSE55257
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | whole organism (development stage: wandering third instar larva) | Eye-Antennal discs | Permissive
      
      Robust | Drosophila melanogaster | GSE59078
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | normal temperature | Permissive
      
      Robust | Drosophila melanogaster | GSE62904
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | heat shock | Permissive
      
      Robust | Drosophila melanogaster | GSE62904
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | Kc167 (development stage: embryonic) | treatment with decapentaplegic (DPP) | Permissive
      
      Robust | Drosophila melanogaster | GSE68654
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | S2 (Schneider 2) | 100mM CuSO4 24 h after seading cells | Permissive
      
      Robust | Drosophila melanogaster | GSE96581
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: IFNb treated 6hr, eGFP(EP mRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: IFNb treated 6hr, IAV NS1(EP mRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: untreated, eGFP(EP mRNA), siCtrl(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siCtrl(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 0hr, IAV NS1(EP mRNA), siCtrl(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siCtrl(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siCtrl(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siNIPBL(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siNIPBL(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siNIPBL(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA), siWAPL(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA), siWAPL(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 7hr+Flavopiridol 3hr, IAV NS1(EP mRNA), siWAPL(siRNA) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: untreated | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 20min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Pam3csk4 treated (025m) | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 30min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 45min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 60min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 120min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 150min + Flavopiridol 30min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 180min + Flavopiridol 60min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: Pam3csk4 treated 360min + Flavopiridol 240min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment:  Flavopiridol 240min | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: untreated | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | Treatment: dexamethasone 6hr | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: mock infected 6hr | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: H5N1 IAV infected 6hr | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: H5N1-dNS1 IAV infected 6hr | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: IFNb treated 6hr | Permissive
      
      Robust | Homo sapiens | GSE103477
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA09 (embryonic stem cells) | Treatment: under normal conditions | Permissive
      
      Robust | Homo sapiens | GSE105028
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA09 (embryonic stem cells) | Treatment: under heat shock conditions | Permissive
      
      Robust | Homo sapiens | GSE105028
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA09 (embryonic stem cells) | Treatment: under normal conditions | Permissive
      
      Robust | Homo sapiens | GSE105028
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA09 (embryonic stem cells) | Treatment: under heat shock conditions | Permissive
      
      Robust | Homo sapiens | GSE105028
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa (cervical adenocarcinoma) | Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-SHB_1-gRNA-GFP | Permissive
      
      Robust | Homo sapiens | GSE107607
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa (cervical adenocarcinoma) | Plasmids: GK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152_3-gRNA-GFP | Permissive
      
      Robust | Homo sapiens | GSE107607
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa (cervical adenocarcinoma) | Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-CCDC85C_3-gRNA-GFP | Permissive
      
      Robust | Homo sapiens | GSE107607
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa (cervical adenocarcinoma) | Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152-gRNA-GFP | Permissive
      
      Robust | Homo sapiens | GSE107607
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) | treatment: no block with TSA CellPopulation:synchronized | Permissive
      
      Robust | Homo sapiens | GSE108173
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) | treatment: no block with TSA CellPopulation:synchronized | Permissive
      
      Robust | Homo sapiens | GSE108173
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) | treatment: no block with TSA CellPopulation:unsynchronized | Permissive
      
      Robust | Homo sapiens | GSE108173
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) | treatment: no block with TSA CellPopulation:unsynchronized | Permissive
      
      Robust | Homo sapiens | GSE108173
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | LUHMES (lund human mesencephalic cells) | Sex: female Passages: 3-10 Stage: neural progenitor cells, undifferentiated Treatment: Prior to differentiation, cells were seeded at 3.5 x 10^6 per T75 flask containing complete growth medium and incubated at 37 °C for 24 hr | Permissive
      
      Robust | Homo sapiens | GSE109706
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | LUHMES (lund human mesencephalic cells) | Sex: female Passages: 3-10 Stage: dopaminergic neurons, differentiated Treatment: For induction of differentiation, culture medium was changed to freshly prepare DMEM:F12 with 2 mM L-glutamine, 1X N-2, 1 mM cAMP (Carbosynth, Cat # ND07996), 1 mg/mL tetracycline (Sigma, Cat # T7660), and 2 ng/mL glial cell line-derived neurotrophic factor (GDNF) (Sigma, Cat # G1777) | Permissive
      
      Robust | Homo sapiens | GSE109706
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: mock infected, time post infection 24 hr | Permissive
      
      Robust | Homo sapiens | GSE118305
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025 | Permissive
      
      Robust | Homo sapiens | GSE118305
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDM(monocyte derived macrophages) | Treatment: ZIKV-bystander, time post infection 24 hr  ViralStrain: ZIKV-FSS13025 | Permissive
      
      Robust | Homo sapiens | GSE118305
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ID00014 (lymphoblastoid cell, DiGeorge syndrome) | Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 34 | Permissive
      
      Robust | Homo sapiens | GSE76922
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ID00015 (lymphoblastoid cell) | Genotype: wildtype Cell type: lymphoblastoid cell | Permissive
      
      Robust | Homo sapiens | GSE76922
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ID00014 (lymphoblastoid cell, DiGeorge syndrome) | Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 11 | Permissive
      
      Robust | Homo sapiens | GSE76922
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MIA PaCa-2 (pancreatic ductal adenocarcinoma) | Treatment: none | Permissive
      
      Robust | Homo sapiens | GSE88734
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) | Genotype: wildtype | Permissive
      
      Robust | Homo sapiens | GSE97394
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) | Genotype: CTCF knockout | Permissive
      
      Robust | Homo sapiens | GSE97394
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CH12 (lymphoma) | Treatment: no Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE98119
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CH12 (lymphoma) | Treatment: no Genotype: CTCFmZF9to11 | Permissive
      
      Robust | Mus musculus | GSE98119
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ES cells (plasmacytomas) | Treatment: no Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE98119
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CH12 (lymphoma) | Treatment: no Genotype: SA deletion | Permissive
      
      Robust | Mus musculus | GSE98119
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | activated B-cells | Treatment: activated, 30hr, UH no treated Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE98119
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver | Sex: male Strain: Crl:CD1(ICR) (Charles River, strain code #022) | Permissive
      
      Robust | Mus musculus | GSE102997
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NIH 3T3 (embryonic fibroblasts) | Stable integrate: N/A Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs | Permissive
      
      Robust | Mus musculus | GSE103198
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NIH 3T3 (embryonic fibroblasts) | Stable integrate: pBI-EGFP-FLAG-mCtcfl and pTA-N Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs | Permissive
      
      Robust | Mus musculus | GSE103198
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P19 (embryonic carcinoma) | Treatment: Cells were kept in DMEM supplemented with 2 ug/ml Doxycycline for 48 hrs | Permissive
      
      Robust | Mus musculus | GSE103198
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | flow sorted pre-B cells | Genotype: B220+CD19+CD43-CD25+IgM- Age: 3 months Tissue: bone marrow Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109671
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | flow sorted pre-B cells | Genotype: B220+CD19+CD43-CD25+IgM- Age: 18 -22  months Tissue: bone marrow Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109671
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Rod_I_Y-8602 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Bipo_I_Y-rM0401 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Bipo_I_Y-rM0405 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Bipo_I_Y-208.03 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Bipo_I_Y-208.04 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_I_Y-207.11 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_Y-rCr33.01 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_Y-rCr33.04 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_Y-Cr143.01 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_Y-263.08 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Amac_M_Y-30.02 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Cone_I_Y-209.11 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Cone_I_Y-209.12 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Cone_I_Y-209.13 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Cone_M_Y-257.03 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: RodFibr_F_Y-FNR07 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Bipo_I_N-rM0408 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: MullFibr_F_N-FCR01 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: MullFibr_F_N-FCR02 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: AmacFibr_F_N-fG140.02 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_N-rCr33.05 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_N-rCr263.4 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Cone_I_N-rCh209.04 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Mull_M_N-rCr143.02 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Amac_I_N-rG79.04 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | induced pluripotent stem cells | Cell line: Cone_M_N-rCh257.4 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NRL-GFP sorted Rod cell postnatal day 21 | Cell line: CTCF-NRL-Rod_M_N-P21 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NRL-GFP sorted Rod cell postnatal day 6 | Cell line: CTCF-NRL-Rod_M_N-P6 Strain: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE109712
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells | Strain: C57BL/6 Genotype: RAG1-/-  Treatment: cultured with IL7 | Permissive
      
      Robust | Mus musculus | GSE109909
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pre-B cells | Strain: C57BL/6 Genotype: RAG1-/- u+ | Permissive
      
      Robust | Mus musculus | GSE109909
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM17942 (lymphoblastoid cell) | Genotype: 22q11 deletion Cell type: lymphoblastoid cell Age: 6 | Permissive
      
      Robust | Homo sapiens | GSE76922
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM12878 (female B-cells lymphoblastoid cell line) | Genotype: wildtype Cell type: lymphoblastoid cell Age: no | Permissive
      
      Robust | Homo sapiens | GSE76922
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MC3T3-E1 (preosteoblasts) | Passage: 28 -31 Day:0 Strain: C57BL/6 Celltype: preosteoblast | Permissive
      
      Robust | Mus musculus | GSE55045
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MC3T3-E1 (preosteoblasts) | Passage: 28 -31 Day:9 Strain: C57BL/6 Celltype: matrix-depositing osteoblast | Permissive
      
      Robust | Mus musculus | GSE55045
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MC3T3-E1 (preosteoblasts) | Passage: 28 -31 Day:28 Strain: C57BL/6 Celltype: mineralizing osteoblast | Permissive
      
      Robust | Mus musculus | GSE55045
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Th2-cells | Treatment: C57BL/6 | Permissive
      
      Robust | Mus musculus | GSE66343
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | EL4 (lymphoma) | Treatment: C57BL/6 Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE66343
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | EL4 (lymphoma) | Treatment: C57BL/6 Genotype: CTCF-motif knockout Treatment: Genome Editing was carried out by CRISPR/Cas9 system | Permissive
      
      Robust | Mus musculus | GSE66343
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ES-E14 (E14, embryonic stem cells) | Genotype: Mll3-/- Mll4-/- (double knockout) dead Cas9 protein (dCas9) without  MLL3SET domain | Permissive
      
      Robust | Mus musculus | GSE74055
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ES-E14 (E14, embryonic stem cells) | Genotype: Mll3-/- Mll4-/- (double knockout), dCas9-MLL3SET fusion protein | Permissive
      
      Robust | Mus musculus | GSE74055
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | nephron progenitors | Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW | Permissive
      
      Robust | Mus musculus | GSE90016
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | nephron progenitors | Genotype: wildtype Age: E16.5 (developing stage) Strain: CFW | Permissive
      
      Robust | Mus musculus | GSE90016
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow | Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: wildtype Source: DN2 cells Age: adult | Permissive
      
      Robust | Mus musculus | GSE90958
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow | Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult | Permissive
      
      Robust | Mus musculus | GSE90958
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow | Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoD+/p(A) Source: DN2 cells Age: adult | Permissive
      
      Robust | Mus musculus | GSE90958
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow | Treatment: cell suspension were incubated with CD3e, B220, CD11b, GR1, TER119, CD117 and Flt3 Strain: C57BL/6 Genotype: ThymoDp(A)/p(A) Source: DN2 cells Age: adult | Permissive
      
      Robust | Mus musculus | GSE90958
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | AML12 | Treatment: shRNA infected, shCtrl Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE95113
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | AML12 | Treatment: shRNA infected, shU Genotype: HNRNPU knockdown | Permissive
      
      Robust | Mus musculus | GSE95113
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | in-vitro differentiated neural progenitor cells (NPC) | Genotype: Sox1-GFP Protocol: sorting GFP+ | Permissive
      
      Robust | Mus musculus | GSE96107
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | in-vitro differentiated neural progenitor cells (NPC) | Genotype: Sox1-GFP Protocol: sorting GFP+ | Permissive
      
      Robust | Mus musculus | GSE96107
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | in-vitro differentiated cortical neurons (CN) | Genotype: Tau-GFP Protocol: sorting GFP+ | Permissive
      
      Robust | Mus musculus | GSE96107
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | in-vitro differentiated cortical neurons (CN) | Genotype: Tau-GFP Protocol: sorting GFP+ | Permissive
      
      Robust | Mus musculus | GSE96107
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Genotype: Oct4-GFP Protocol: sorting GFP+ | Permissive
      
      Robust | Mus musculus | GSE96107
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | primary cells (short term) | Treatment: C/EBPa was induced with beta-estradiol, day2 | Permissive
      
      Robust | Mus musculus | GSE96548
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | primary cells (short term) | Treatment: C/EBPa was induced with beta-estradiol, day4 | Permissive
      
      Robust | Mus musculus | GSE96548
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | primary cells (short term) | Treatment: C/EBPa was induced with beta-estradiol, day6 | Permissive
      
      Robust | Mus musculus | GSE96548
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | primary cells (short term) | Treatment: C/EBPa was induced with beta-estradiol, day8 | Permissive
      
      Robust | Mus musculus | GSE96548
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cardiac myocytes | Tissue: Left ventricle Strain :C57BL/6 Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE96691
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cardiac myocytes | Tissue: Left ventricle Strain :C57BL/6 Genotype: CTCF knockout | Permissive
      
      Robust | Mus musculus | GSE96691
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | jejunal epithelial cells | Treatment: sunflower oil (vehicle for tamoxifen)  Genotype: wildtype (Cdx2 f/f (cdx2 knockout))  Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine | Permissive
      
      Robust | Mus musculus | GSE98724
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Genotype: wildtype Strain: C57bl/6 | Permissive
      
      Robust | Mus musculus | GSE99530
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Genotype: mll2 knockout by Cre-recombination Strain: C57bl/6 | Permissive
      
      Robust | Mus musculus | GSE99530
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells-derived clonal neural progenitor cells | Source: neural progenitor cells Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE99991
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells-derived clonal neural progenitor cells | Source: neural progenitor cells Genotype: Smchd1-/- | Permissive
      
      Robust | Mus musculus | GSE99991
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells-derived clonal neural progenitor cells | Source: neural progenitor cells Genotype: wildtype | Permissive
      
      Robust | Mus musculus | GSE99991
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells-derived clonal neural progenitor cells | Source: neural progenitor cells Genotype: Smchd1-/- | Permissive
      
      Robust | Mus musculus | GSE99991
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: no stress  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: no stress  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 7.5 min  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 30 min  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: no stress  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: triploide, no stress  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 60 min  Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | Treatment: pre treatment with 500 nM triptolide for 2 hrs, 110 mM NaCl for 60 min  + triptolide Source: T47D whole cell | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | T47D (invasive ductal carcinoma) | 110 mM NaCl | Permissive
      
      Robust | Homo sapiens | GSE111923
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | EOL-1 (Acute myeloid leukemia) | Treatment: untreated | Permissive
      
      Robust | Homo sapiens | GSE113040
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MOLM-13(acute monocytic leukemia(AML), Homo sapiens) | Treatment: treated with 1:10.000 DMSO for 48hr | Permissive
      
      Robust | Homo sapiens | GSE113040
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | SYO-1(Biphasic synovial sarcoma) | Treatment: lentivirally infected with shControl | Permissive
      
      Robust | Homo sapiens | GSE113040
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Jurkat (T-cells) | Treatment: untreated | Permissive
      
      Robust | Homo sapiens | GSE113040
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | TTC-1240 (Rhabdoid tumor of the kidney) | Treatment: lentivirally infected with empty vector control | Permissive
      
      Robust | Homo sapiens | GSE113040
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | EndoC-BH1 (human pancreatic beta cell line) | Source: Pancreas | Permissive
      
      Robust | Homo sapiens | GSE118588
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: Wt2A1 Genotype: wildtype Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: Mut5A6 Genotype: SmcHD1 MomeD1 mutant Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: A3-3 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Clone: D4 Genotype: CRISPR knockout of SmcHD1 Sex:female  Background genotype: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus | Permissive
      
      Robust | Mus musculus | GSE111820
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G4 (embryonic stem cells) | Developmental stage: E11.5 Genotype: Inv1 | Permissive
      
      Robust | Mus musculus | GSE116790
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G4 (embryonic stem cells) | Developmental stage: E11.5 Genotype: Inv1DelCTCF | Permissive
      
      Robust | Mus musculus | GSE116790
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G4 (embryonic stem cells) | Genotype: Inv1 | Permissive
      
      Robust | Mus musculus | GSE116790
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryoid body (day 6) | Strain: Outbred - B6:129Sv Passage: From 8 to 12 Age: day 6 Cell type: Day 6 embryoid bodies from mouse embryonic stem cells | Permissive
      
      Robust | Mus musculus | GSE119874
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female | Permissive
      
      Robust | Mus musculus | GSE122019
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female | Permissive
      
      Robust | Mus musculus | GSE122019
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Genotype: wildtype Clone: Wt2A1 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female | Permissive
      
      Robust | Mus musculus | GSE122019
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female | Permissive
      
      Robust | Mus musculus | GSE122019
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female | Permissive
      
      Robust | Mus musculus | GSE122019
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | clonal MEF | Genotype: SmcHD1 MomeD1 mutant Clone: Mut5A6 Genetic background: Inter-specific: F2, M.m.domesticus FVB x M.m.Castaneus Sex: female | Permissive
      
      Robust | Mus musculus | GSE122019
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HNEK (epidermal keratinocytes) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NHLF (lung fibroblasts) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUVEC-C (HUVEC, umbilical vein endothelial cells) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HMEC (human mammary epithelial cells) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NHDF-Ad (adult dermal fibroblasts) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM12878 (female B-cells lymphoblastoid cell line) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HSMM (skeletal muscle myoblasts) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NA-A (astrocytes) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HSMM dirived skeletal muscle myotubes | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | osteoblasts | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | DND41 (acute lymphoblastic leukemia) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD20+ | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | RO01746 (CD14+ monocytes) | Treatment: None; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | Treatment: 1 h with 0.02% Ethanol; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) | Treatment: 1 h with 100 nM Dexamethasone; | Permissive
      
      Robust | Homo sapiens | GSE29611
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HAP1 (chronic myelogenous leukemia) | Genotype: wildtype; | Permissive
      
      Robust | Homo sapiens | GSE94992
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HAP1 (chronic myelogenous leukemia) | Genotype: Wapl and SCC4 knockout; | Permissive
      
      Robust | Homo sapiens | GSE94992
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | whole brain | Developmental stage: Embryonic day 14.5; | Permissive
      
      Robust | Mus musculus | GSE36027
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | trophoblast stem cells | Strain: CD1(ICR); Developmental stage: blastocysts, cecle stage G1; | Permissive | Mus musculus | GSE41371
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | trophoblast stem cells | Strain: CD1(ICR); Developmental stage: blastocysts, S cycle stage; | Permissive | Mus musculus | GSE41371
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | trophoblast stem cells | Strain: CD1(ICR); Developmental stage: blastocysts, cycle stage M; | Permissive
      
      Robust | Mus musculus | GSE41371
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts | Strain: mixed C57BL/6 and 129 background; Genotype: Wapl +/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM; | Permissive
      
      Robust | Mus musculus | GSE41602
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts | Strain: mixed C57BL/6 and 129 background; Genotype: Wapl -/delta; Treatment: 4-OHT was added to the starvation medium to a final concentration of 500 nM; | Permissive
      
      Robust | Mus musculus | GSE41602
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pancreas | Strain: C57BL/6; Age: 8-10 week old; | Permissive
      
      Robust | Mus musculus | GSE59119
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7L-P(immortalized breast epithelial cell line) | Treatment: untreated; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 1 hr; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 4 hrs; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 16 hrs; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7L-P(immortalized breast epithelial cell line) | Treatment: treated with E2 for 24 hrs; | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | olfactory neurons | Genotype: tetotet3iresgfp, omptta (overexpressing Tet3); | Permissive
      
      Robust | Mus musculus | GSE115862
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | olfactory neurons | Genotype: tetogfp, omptta; | Permissive
      
      Robust | Mus musculus | GSE115862
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MDA-MB-157 (triple negative breast carcinoma) | Treatment: untreated; | Permissive
      
      Robust | Homo sapiens | GSE116868
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HT1080 (fibrosarcoma) | Treatment: none; | Permissive
      
      Robust | Homo sapiens | GSE122462
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HT1080 (fibrosarcoma) | Treatment: 3 uM final concentration of CBL0137 for 6hrs; | Permissive
      
      Robust | Homo sapiens | GSE122462
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HT1080 (fibrosarcoma) | Treatment: none; | Permissive
      
      Robust | Homo sapiens | GSE122462
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HT1080 (fibrosarcoma) | Treatment: 3 uM final concentration of CBL0137 for 6hrs; | Permissive
      
      Robust | Homo sapiens | GSE122462
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | telencephalon | Developmental stage: E13.5; | Permissive
      
      Robust | Mus musculus | GSE105071
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | medial ganglionic eminence | Developmental stage: E13.5; | Permissive
      
      Robust | Mus musculus | GSE105071
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: wildtype; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: Snf2h knockout; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: wildtype; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: wildtype; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: Brg1 knockout; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: Brg1 knockout; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: Snf2h knockout, Snf2h wiltype add-back; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Strain: 129S6/SvEvTac; Genotype: Snf2h ko, Snf2h mutant add-back; | Permissive
      
      Robust | Mus musculus | GSE112132
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mESCs (mouse embryonic stem cells) | Genotype: TET1/2 double knockout; | Permissive
      
      Robust | Mus musculus | GSE114599
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mESCs (mouse embryonic stem cells) | Genotype: TET1/2 double knockout; | Permissive
      
      Robust | Mus musculus | GSE114599
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mESCs (mouse embryonic stem cells) | Genotype: wildtype; | Permissive
      
      Robust | Mus musculus | GSE114599
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mESCs (mouse embryonic stem cells) | Genotype: wildtype; | Permissive
      
      Robust | Mus musculus | GSE114599
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant; | Permissive
      
      Robust | Mus musculus | GSE119697
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Treatment: none; Strain: CAST/Ei x 129/Sv/Jae; Genotype: CTCF Ser224-P phospho-mimic mutant; | Permissive
      
      Robust | Mus musculus | GSE119697
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation; | Permissive
      
      Robust | Mus musculus | GSE126362
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Treatment: no doxycycline; Developmental stage: day4 of differentiation; | Permissive
      
      Robust | Mus musculus | GSE126362
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells | Treatment: doxycycline for 1 day; Developmental stage: day4 of differentiation; | Permissive
      
      Robust | Mus musculus | GSE126362
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | Genotype: Luc knockdown; Treatment: 94 hours knockdown induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | Genotype: Luc knockdown; Treatment: 95 hours knockdown induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | Genotype: Stag2 knockdown; Treatment: 96 hours knock-down induction with Doxycycline with shStag2; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | Genotype: Stag2 knockdown; Treatment: 97 hours knock-down induction with Doxycycline with shStag2; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | Genotype: Rad21 knockdown; Treatment: 98 hours knock-down induction with Doxycycline with shRad21; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) | Genotype: Rad21 knockdown; Treatment: 99 hours knock-down induction with Doxycycline with shRad21; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 derived erythroid cells | Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 80 hours knockdown induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 derived erythroid cells | Conditions: 4 U/l EPO; Genotype: Luc knockdown; Treatment: 81 hours knockdown induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 derived erythroid cells | Conditions: 4 U/l EPO;  Genotype: Stag2 knockdown; Treatment: 82 hours knock-down induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | myeloid malignancies | Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 76 hours knockdown induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | myeloid malignancies | Conditions: 50 ng/ul IL-3; Genotype: Luc knockdown; Treatment: 77 hours knockdown induction with Doxycycline; | Permissive
      
      Robust | Mus musculus | GSE129478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: deltaCTCF i4; Developmental stage: E10.5; Strain: G4; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: deltaCTCF i5; Developmental stage: E10.5; Strain: G4; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: wildtype CTCF; Developmental stage: E10.5; Strain: G4; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: delta-CTCF i4i5ZRSreg; Developmental stage: E10.5; Strain: G4; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: deltaCTCF i4i5; Developmental stage: E10.5; Strain: G4; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: deltaCTCF i4i5ZRS; Developmental stage: E10.5; Strain: G4; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fetal limb bud and midbrain | Genotype: wildtype; Developmental stage: E10.5; Strain: Bl.6; | Permissive
      
      Robust | Mus musculus | GSE123386
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebellum | Genotype: Ai32 fl/fl; Age: 6-8weeks; | Permissive
      
      Robust | Mus musculus | GSE127995
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebellum | Genotype: Atoh1-CRE, Ai32 fl/fl; Age: 6-8weeks; | Permissive
      
      Robust | Mus musculus | GSE127995
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Abelson-transformed pre-B cell | Genotype: Lig4-/-(knockout); Strain: C57BL/6; | Permissive
      
      Robust | Mus musculus | GSE129526
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone-marrow derived primary pre B cells | Age: adult; Strain: C57BL/6 x 129/Sv; Source: large pre-B; Genotype: wildtype; | Permissive
      
      Robust | Mus musculus | GSE130315
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) | Conditions: cultured in 2i medium for 3 days; | Permissive
      
      Robust | Mus musculus | GSE92407
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) | Conditions: cultured in EpiLSCs medium; | Permissive
      
      Robust | Mus musculus | GSE92407
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) | Conditions: cultured in serum medium; | Permissive
      
      Robust | Mus musculus | GSE92407
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | TAM | Permissive
      
      Robust | Homo sapiens | ERP000783 | MA0139.1 | 
  
    
    | CTCF |  | BLOOD | Permissive
      
      Robust | Homo sapiens | GSE43098 | MA0139.1 | 
  
    
    | CTCF |  | blood | Permissive
      
      Robust | Homo sapiens | GSE46832 | MA0139.1 | 
  
    
    | CTCF |  | naive | Permissive | Homo sapiens | GSE74850 | MA0139.1 | 
  
    
    | CTCF | RCC 7860 (Renal cell carcinoma) | NORMOXIA | Permissive
      
      Robust | Homo sapiens | GSE78113 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AHD | MA0139.1 | 
  
    
    | CTCF | GM12878 (female B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AKB | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AKO | MA0139.1 | 
  
    
    | CTCF | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ALA | MA0139.1 | 
  
    
    | CTCF | keratinocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ALJ | MA0139.1 | 
  
    
    | CTCF | mammary epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ALV | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AMA | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AMF | MA0139.1 | 
  
    
    | CTCF | skeletal muscles and myoblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ANE | MA0139.1 | 
  
    
    | CTCF | normal lung fibroblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ANO | MA0139.1 | 
  
    
    | CTCF | myotube |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ANS | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AOA | MA0139.1 | 
  
    
    | CTCF | astrocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AOO | MA0139.1 | 
  
    
    | CTCF | osteoblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000APF | MA0139.1 | 
  
    
    | CTCF | fibroblast of dermis |  | Permissive
      
      Robust | Homo sapiens | ENCSR000APM | MA0139.1 | 
  
    
    | CTCF | DND41 (acute lymphoblastic leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AQU | MA0139.1 | 
  
    
    | CTCF | CD14+ monocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR000ATN | MA0139.1 | 
  
    
    | CTCF | B-cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000AUV | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BIE | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BNH | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BPJ | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BSE | MA0139.1 | 
  
    
    | CTCF | D54 (H54, Human glioblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKN | MA0139.1 | 
  
    
    | CTCF | GM10248 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKP | MA0139.1 | 
  
    
    | CTCF | GM10266 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKR | MA0139.1 | 
  
    
    | CTCF | GM12878 (female B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKV | MA0139.1 | 
  
    
    | CTCF | GM12891 (male B- cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKX | MA0139.1 | 
  
    
    | CTCF | GM12892 (female B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKY | MA0139.1 | 
  
    
    | CTCF | GM13977 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLB | MA0139.1 | 
  
    
    | CTCF | GM19238 (female B-cells lymphoblastoid cell lines) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLD | MA0139.1 | 
  
    
    | CTCF | GM19239 (male B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLE | MA0139.1 | 
  
    
    | CTCF | GM19240 (B cells Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLF | MA0139.1 | 
  
    
    | CTCF | GM20000 (B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLG | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLK | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLO | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLS | MA0139.1 | 
  
    
    | CTCF | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DLW | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMA | MA0139.1 | 
  
    
    | CTCF | kidney |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMC | MA0139.1 | 
  
    
    | CTCF | LNCaP clone FGC |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMF | MA0139.1 | 
  
    
    | CTCF | lung |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMH | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DML | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMO | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMR | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMV | MA0139.1 | 
  
    
    | CTCF | medulloblastoma |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DMY | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DNA | MA0139.1 | 
  
    
    | CTCF | keratinocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DNC | MA0139.1 | 
  
    
    | CTCF | pancreas |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DND | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DNI | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPF | MA0139.1 | 
  
    
    | CTCF | AG04449 (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPG | MA0139.1 | 
  
    
    | CTCF | AG04450 (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPM | MA0139.1 | 
  
    
    | CTCF | AG09309 (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPP | MA0139.1 | 
  
    
    | CTCF | AG09319 (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPS | MA0139.1 | 
  
    
    | CTCF | AG10803 (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPV | MA0139.1 | 
  
    
    | CTCF | aortic adventitial fibroblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DPY | MA0139.1 | 
  
    
    | CTCF | BE2C |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DQD | MA0139.1 | 
  
    
    | CTCF | BJ (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DQI | MA0139.1 | 
  
    
    | CTCF | Caco-2 (colon adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DQN | MA0139.1 | 
  
    
    | CTCF | GM06990 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DQW | MA0139.1 | 
  
    
    | CTCF | GM12801 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DQY | MA0139.1 | 
  
    
    | CTCF | GM12864 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRB | MA0139.1 | 
  
    
    | CTCF | GM12865 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRE | MA0139.1 | 
  
    
    | CTCF | GM12866 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRF | MA0139.1 | 
  
    
    | CTCF | GM12867 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRH | MA0139.1 | 
  
    
    | CTCF | GM12868 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRI | MA0139.1 | 
  
    
    | CTCF | GM12869 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRJ | MA0139.1 | 
  
    
    | CTCF | GM12870 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRK | MA0139.1 | 
  
    
    | CTCF | GM12872 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRN | MA0139.1 | 
  
    
    | CTCF | GM12873 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRP | MA0139.1 | 
  
    
    | CTCF | GM12874 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRR | MA0139.1 | 
  
    
    | CTCF | GM12875 (female B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRU | MA0139.1 | 
  
    
    | CTCF | human astrocytes-spinal cord |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DSU | MA0139.1 | 
  
    
    | CTCF | human brain microvascular endothelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTA | MA0139.1 | 
  
    
    | CTCF | human cardiac fibroblasts-adult atrial |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTF | MA0139.1 | 
  
    
    | CTCF | human cardiac myocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTI | MA0139.1 | 
  
    
    | CTCF | HCPEpiC (choroid plexus epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTL | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTO | MA0139.1 | 
  
    
    | CTCF | esophageal epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTR | MA0139.1 | 
  
    
    | CTCF | HEK293 (embryonic kidney) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DTW | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUB | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUG | MA0139.1 | 
  
    
    | CTCF | primary foreskin fibroblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUH | MA0139.1 | 
  
    
    | CTCF | HFF-Myc (fetal fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUM | MA0139.1 | 
  
    
    | CTCF | HL-60 (acute myeloid leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUP | MA0139.1 | 
  
    
    | CTCF | mammary epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUS | MA0139.1 | 
  
    
    | CTCF | fibroblast of mammary gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUU | MA0139.1 | 
  
    
    | CTCF | fibroblast of pulmonary artery |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DUX | MA0139.1 | 
  
    
    | CTCF | normal lung fibroblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DVA | MA0139.1 | 
  
    
    | CTCF | kidney epithelial cell |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DVH | MA0139.1 | 
  
    
    | CTCF | retinal pigment epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DVI | MA0139.1 | 
  
    
    | CTCF | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DVP | MA0139.1 | 
  
    
    | CTCF | human villous mesenchymal fibroblast cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DVQ | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DWE | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DWH | MA0139.1 | 
  
    
    | CTCF | NB4 (acute promyelocytic leukemia ) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DWN | MA0139.1 | 
  
    
    | CTCF | primary foreskin fibroblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DWQ | MA0139.1 | 
  
    
    | CTCF | keratinocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DWX | MA0139.1 | 
  
    
    | CTCF | normal lung fibroblasts |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DWY | MA0139.1 | 
  
    
    | CTCF | epithelial cell of proximal tubule |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DXD | MA0139.1 | 
  
    
    | CTCF | bronchial epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DXI | MA0139.1 | 
  
    
    | CTCF | WERI-Rb-1 (retinoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DXW | MA0139.1 | 
  
    
    | CTCF | WI-38 (lung fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DYB | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DYD | MA0139.1 | 
  
    
    | CTCF | IMR90 (lung fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000EFI | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000EGM | MA0139.1 | 
  
    
    | CTCF | SK-N-SH (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000EIC | MA0139.1 | 
  
    
    | CTCF | OCI-LY7 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR027HML | MA0139.1 | 
  
    
    | CTCF | DOHH2 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR084RDK | MA0139.1 | 
  
    
    | CTCF | KARPAS-422 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR113REG | MA0139.1 | 
  
    
    | CTCF | SU-DHL-6 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR125DKL | MA0139.1 | 
  
    
    | CTCF | Loucy (adult T acute lymphoblastic leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR464DKE | MA0139.1 | 
  
    
    | CTCF | neural cell |  | Permissive
      
      Robust | Homo sapiens | ENCSR822CEA | MA0139.1 | 
  
    
    | CTCF | sigmoid colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR721AHD | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Homo sapiens | ENCSR692ILH | MA0139.1 | 
  
    
    | CTCF | lower leg skin |  | Permissive
      
      Robust | Homo sapiens | ENCSR252XWG | MA0139.1 | 
  
    
    | CTCF | esophagus muscularis mucosa |  | Permissive
      
      Robust | Homo sapiens | ENCSR559KAB | MA0139.1 | 
  
    
    | CTCF | heart left ventricle |  | Permissive
      
      Robust | Homo sapiens | ENCSR544APK | MA0139.1 | 
  
    
    | CTCF | esophagus muscularis mucosa |  | Permissive
      
      Robust | Homo sapiens | ENCSR353DFU | MA0139.1 | 
  
    
    | CTCF | adrenal gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR770IWO | MA0139.1 | 
  
    
    | CTCF | adrenal gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR899JSO | MA0139.1 | 
  
    
    | CTCF | esophagus squamous epithelium |  | Permissive
      
      Robust | Homo sapiens | ENCSR773JBP | MA0139.1 | 
  
    
    | CTCF | esophagus squamous epithelium |  | Permissive
      
      Robust | Homo sapiens | ENCSR003SZZ | MA0139.1 | 
  
    
    | CTCF | esophagus squamous epithelium |  | Permissive
      
      Robust | Homo sapiens | ENCSR450FRI | MA0139.1 | 
  
    
    | CTCF | subcutaneous adipose tissue |  | Permissive
      
      Robust | Homo sapiens | ENCSR790VEV | MA0139.1 | 
  
    
    | CTCF | breast epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR697YIN | MA0139.1 | 
  
    
    | CTCF | tibial nerve |  | Permissive
      
      Robust | Homo sapiens | ENCSR822PJT | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Homo sapiens | ENCSR234HEM | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR608WPS | MA0139.1 | 
  
    
    | CTCF | gastroesophageal sphincter |  | Permissive
      
      Robust | Homo sapiens | ENCSR186NVR | MA0139.1 | 
  
    
    | CTCF | Peyer's patch |  | Permissive
      
      Robust | Homo sapiens | ENCSR375VXU | MA0139.1 | 
  
    
    | CTCF | epithelial cell of prostate |  | Permissive
      
      Robust | Homo sapiens | ENCSR196HOM | MA0139.1 | 
  
    
    | CTCF | RWPE2 |  | Permissive
      
      Robust | Homo sapiens | ENCSR856JJB | MA0139.1 | 
  
    
    | CTCF | VCaP (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR265ARE | MA0139.1 | 
  
    
    | CTCF | gastroesophageal sphincter |  | Permissive
      
      Robust | Homo sapiens | ENCSR661XNQ | MA0139.1 | 
  
    
    | CTCF | stomach |  | Permissive
      
      Robust | Homo sapiens | ENCSR618QYE | MA0139.1 | 
  
    
    | CTCF | testis |  | Permissive
      
      Robust | Homo sapiens | ENCSR981CID | MA0139.1 | 
  
    
    | CTCF | lower leg skin |  | Permissive | Homo sapiens | ENCSR582MTM | MA0139.1 | 
  
    
    | CTCF | neutrophils |  | Permissive
      
      Robust | Homo sapiens | ENCSR785YRL | MA0139.1 | 
  
    
    | CTCF | Peyer's patch |  | Permissive
      
      Robust | Homo sapiens | ENCSR799WDT | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR558HTE | MA0139.1 | 
  
    
    | CTCF | upper lobe of left lung |  | Permissive
      
      Robust | Homo sapiens | ENCSR972LYL | MA0139.1 | 
  
    
    | CTCF | testis |  | Permissive
      
      Robust | Homo sapiens | ENCSR494TNM | MA0139.1 | 
  
    
    | CTCF | stomach |  | Permissive | Homo sapiens | ENCSR776AEL | MA0139.1 | 
  
    
    | CTCF | lower leg skin |  | Permissive
      
      Robust | Homo sapiens | ENCSR430TEE | MA0139.1 | 
  
    
    | CTCF | ascending aorta |  | Permissive
      
      Robust | Homo sapiens | ENCSR960MDF | MA0139.1 | 
  
    
    | CTCF | prostate gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR720USO | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Homo sapiens | ENCSR028YEV | MA0139.1 | 
  
    
    | CTCF | pancreas |  | Permissive
      
      Robust | Homo sapiens | ENCSR307PFP | MA0139.1 | 
  
    
    | CTCF | Peyer's patch |  | Permissive
      
      Robust | Homo sapiens | ENCSR391ZKN | MA0139.1 | 
  
    
    | CTCF | sigmoid colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR222SQE | MA0139.1 | 
  
    
    | CTCF | esophagus squamous epithelium |  | Permissive
      
      Robust | Homo sapiens | ENCSR756URL | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | ENCSR362VNF | MA0139.1 | 
  
    
    | CTCF | hepatocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR252QYR | MA0139.1 | 
  
    
    | CTCF | breast epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR661NXJ | MA0139.1 | 
  
    
    | CTCF | thyroid gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR955BIB | MA0139.1 | 
  
    
    | CTCF | suprapubic skin |  | Permissive
      
      Robust | Homo sapiens | ENCSR515LRI | MA0139.1 | 
  
    
    | CTCF | thoracic aorta |  | Permissive
      
      Robust | Homo sapiens | ENCSR668BTN | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR833FWC | MA0139.1 | 
  
    
    | CTCF | stomach |  | Permissive
      
      Robust | Homo sapiens | ENCSR549WAU | MA0139.1 | 
  
    
    | CTCF | PC9 (lung adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR243INX | MA0139.1 | 
  
    
    | CTCF | omental fat pad |  | Permissive
      
      Robust | Homo sapiens | ENCSR005LPI | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR769WKR | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR102CSD | MA0139.1 | 
  
    
    | CTCF | upper lobe of left lung |  | Permissive
      
      Robust | Homo sapiens | ENCSR964BKO | MA0139.1 | 
  
    
    | CTCF | gastrocnemius medialis |  | Permissive
      
      Robust | Homo sapiens | ENCSR071XWO | MA0139.1 | 
  
    
    | CTCF | PANC1 (pancreatic ductal adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR203QEB | MA0139.1 | 
  
    
    | CTCF | lower leg skin |  | Permissive
      
      Robust | Homo sapiens | ENCSR727HME | MA0139.1 | 
  
    
    | CTCF | tibial artery |  | Permissive
      
      Robust | Homo sapiens | ENCSR699BEK | MA0139.1 | 
  
    
    | CTCF | MM1.S (plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR402IDP | MA0139.1 | 
  
    
    | CTCF | ovary |  | Permissive
      
      Robust | Homo sapiens | ENCSR548DDS | MA0139.1 | 
  
    
    | CTCF | suprapubic skin |  | Permissive
      
      Robust | Homo sapiens | ENCSR756KRS | MA0139.1 | 
  
    
    | CTCF | 22RV1 (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR857PBV | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR236YGF | MA0139.1 | 
  
    
    | CTCF | uterus |  | Permissive
      
      Robust | Homo sapiens | ENCSR392SFJ | MA0139.1 | 
  
    
    | CTCF | right lobe of liver |  | Permissive
      
      Robust | Homo sapiens | ENCSR911GFJ | MA0139.1 | 
  
    
    | CTCF | coronary artery |  | Permissive
      
      Robust | Homo sapiens | ENCSR175FLL | MA0139.1 | 
  
    
    | CTCF | pancreas |  | Permissive
      
      Robust | Homo sapiens | ENCSR484DDO | MA0139.1 | 
  
    
    | CTCF | vagina |  | Permissive
      
      Robust | Homo sapiens | ENCSR655ECZ | MA0139.1 | 
  
    
    | CTCF | upper lobe of left lung |  | Permissive
      
      Robust | Homo sapiens | ENCSR027FSZ | MA0139.1 | 
  
    
    | CTCF | LNCaP (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR315NAC | MA0139.1 | 
  
    
    | CTCF | thyroid gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR492ZIW | MA0139.1 | 
  
    
    | CTCF | pancreas |  | Permissive
      
      Robust | Homo sapiens | ENCSR408XTO | MA0139.1 | 
  
    
    | CTCF | adrenal gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR450BLH | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Homo sapiens | ENCSR254YRM | MA0139.1 | 
  
    
    | CTCF | prostate gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR829HTO | MA0139.1 | 
  
    
    | CTCF | breast epithelial cells |  | Permissive
      
      Robust | Homo sapiens | ENCSR304XUZ | MA0139.1 | 
  
    
    | CTCF | gastrocnemius medialis |  | Permissive
      
      Robust | Homo sapiens | ENCSR998NQG | MA0139.1 | 
  
    
    | CTCF | subcutaneous adipose tissue |  | Permissive | Homo sapiens | ENCSR762PCG | MA0139.1 | 
  
    
    | CTCF | sigmoid colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR925GDS | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Homo sapiens | ENCSR482PMN | MA0139.1 | 
  
    
    | CTCF | gastroesophageal sphincter |  | Permissive
      
      Robust | Homo sapiens | ENCSR146BGM | MA0139.1 | 
  
    
    | CTCF | tibial nerve |  | Permissive
      
      Robust | Homo sapiens | ENCSR469POZ | MA0139.1 | 
  
    
    | CTCF | vagina |  | Permissive
      
      Robust | Homo sapiens | ENCSR606TNN | MA0139.1 | 
  
    
    | CTCF | pancreas |  | Permissive
      
      Robust | Homo sapiens | ENCSR572DUJ | MA0139.1 | 
  
    
    | CTCF | suprapubic skin |  | Permissive
      
      Robust | Homo sapiens | ENCSR038FOS | MA0139.1 | 
  
    
    | CTCF | tibial nerve |  | Permissive
      
      Robust | Homo sapiens | ENCSR434XLP | MA0139.1 | 
  
    
    | CTCF | right atrium auricular region |  | Permissive
      
      Robust | Homo sapiens | ENCSR066GBX | MA0139.1 | 
  
    
    | CTCF | Peyer's patch |  | Permissive
      
      Robust | Homo sapiens | ENCSR419ANE | MA0139.1 | 
  
    
    | CTCF | thyroid gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR744YJR | MA0139.1 | 
  
    
    | CTCF | esophagus muscularis mucosa |  | Permissive
      
      Robust | Homo sapiens | ENCSR074SFL | MA0139.1 | 
  
    
    | CTCF | uterus |  | Permissive
      
      Robust | Homo sapiens | ENCSR798NVH | MA0139.1 | 
  
    
    | CTCF | ovary |  | Permissive
      
      Robust | Homo sapiens | ENCSR493APD | MA0139.1 | 
  
    
    | CTCF | heart left ventricle |  | Permissive
      
      Robust | Homo sapiens | ENCSR791AYW | MA0139.1 | 
  
    
    | CTCF | upper lobe of left lung |  | Permissive
      
      Robust | Homo sapiens | ENCSR970UZD | MA0139.1 | 
  
    
    | CTCF | omental fat pad |  | Permissive
      
      Robust | Homo sapiens | ENCSR089DTY | MA0139.1 | 
  
    
    | CTCF | omental fat pad |  | Permissive
      
      Robust | Homo sapiens | ENCSR225OKX | MA0139.1 | 
  
    
    | CTCF | RWPE1 (prostate epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR303GFI | MA0139.1 | 
  
    
    | CTCF | pancreas |  | Permissive
      
      Robust | Homo sapiens | ENCSR265PFQ | MA0139.1 | 
  
    
    | CTCF | stomach |  | Permissive
      
      Robust | Homo sapiens | ENCSR173AIR | MA0139.1 | 
  
    
    | CTCF | adrenal gland |  | Permissive
      
      Robust | Homo sapiens | ENCSR014GSQ | MA0139.1 | 
  
    
    | CTCF | gastrocnemius medialis |  | Permissive
      
      Robust | Homo sapiens | ENCSR428BKN | MA0139.1 | 
  
    
    | CTCF | LNCaP C4-2B (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR460LGH | MA0139.1 | 
  
    
    | CTCF | esophagus squamous epithelium |  | Permissive
      
      Robust | Homo sapiens | ENCSR838RUX | MA0139.1 | 
  
    
    | CTCF | gastroesophageal sphincter |  | Permissive
      
      Robust | Homo sapiens | ENCSR206ETG | MA0139.1 | 
  
    
    | CTCF | transverse colon |  | Permissive
      
      Robust | Homo sapiens | ENCSR907BES | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR240PRQ | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR560BUE | MA0139.1 | 
  
    
    | CTCF | SK-N-SH (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR541AMF | MA0139.1 | 
  
    
    | CTCF | human cardiac myocytes |  | Permissive
      
      Robust | Homo sapiens | ENCSR713SXF | MA0139.1 | 
  
    
    | CTCF | KMS-11 (Plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR430YRJ | MA0139.1 | 
  
    
    | CTCF | A673 (Ewing sarcoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR611JJS | MA0139.1 | 
  
    
    | CTCF | GM23338 |  | Permissive
      
      Robust | Homo sapiens | ENCSR987GXT | MA0139.1 | 
  
    
    | CTCF | H929 (plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR634OAQ | MA0139.1 | 
  
    
    | CTCF | foreskin keratinocyte |  | Permissive
      
      Robust | Homo sapiens | ENCSR817HTJ | MA0139.1 | 
  
    
    | CTCF | neural progenitors |  | Permissive
      
      Robust | Homo sapiens | ENCSR125NBL | MA0139.1 | 
  
    
    | CTCF | PC3(bone mets prostate adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR359LOD | MA0139.1 | 
  
    
    | CTCF | smooth muscle cell |  | Permissive
      
      Robust | Homo sapiens | ENCSR261VAS | MA0139.1 | 
  
    
    | CTCF | OCI-LY1 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR072EUE | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts |  | Permissive
      
      Robust | Mus musculus | GSE22562
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE21365
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived adipocytes |  | Permissive
      
      Robust | Mus musculus | GSE21365
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | R1/E (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE25777
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells |  | Permissive
      
      Robust | Mus musculus | GSE26257
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | V6.5 (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE18699
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | B-cells |  | Permissive
      
      Robust | Mus musculus | GSE33819
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE11431
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE25416
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa S3 (cervical adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25416
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE25416
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE25416
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | normal epidermal keratinocytes |  | Permissive
      
      Robust | Homo sapiens | GSE25416
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells |  | Permissive
      
      Robust | Mus musculus | GSE27214
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mature B-cells |  | Permissive
      
      Robust | Mus musculus | GSE27214
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ES-E14 (E14, embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE28247
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ES-E14 (E14, embryonic stem cells) |  | Permissive | Mus musculus | GSE28247
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE30203
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lymphoblastoid cells |  | Permissive
      
      Robust | Homo sapiens | GSE19622
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lymphoblastoid cells |  | Permissive
      
      Robust | Homo sapiens | GSE19622
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lymphoblastoid cells |  | Permissive
      
      Robust | Homo sapiens | GSE19622
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lymphoblastoid cells |  | Permissive
      
      Robust | Homo sapiens | GSE19622
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lymphoblastoid cells |  | Permissive
      
      Robust | Homo sapiens | GSE19622
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lymphoblastoid cells |  | Permissive
      
      Robust | Homo sapiens | GSE19622
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD34+ hematopoietic stem cells |  | Permissive
      
      Robust | Homo sapiens | GSE26501
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE30226
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE32692
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | FB8470 (fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE32692
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | FB0167P (progeria fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE32692
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | D54 (H54, Human glioblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE32692
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | heart |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBI
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MEL cell line |  | Permissive
      
      Robust | Mus musculus | ENCSR000DIP
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBU
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow-derived macrophages |  | Permissive
      
      Robust | Mus musculus | ENCSR000CFJ
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MEL cell line |  | Permissive
      
      Robust | Mus musculus | ENCSR000ETQ
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | kidney |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBJ
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cortical plate |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBO
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBL
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CH12.LX (Mouse lymphoma) |  | Permissive
      
      Robust | Mus musculus | ENCSR000DIU
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | olfactory bulb |  | Permissive
      
      Robust | Mus musculus | ENCSR000CDX
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G1E (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | ENCSR000DIS
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CH12.LX (Mouse lymphoma) |  | Permissive
      
      Robust | Mus musculus | ENCSR000ERM
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lung |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBV
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MEL cell line |  | Permissive
      
      Robust | Mus musculus | ENCSR000CFH
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | thymus |  | Permissive
      
      Robust | Mus musculus | ENCSR000CDZ
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBW
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebellum |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBN
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | C2C12 (myoblasts) |  | Permissive
      
      Robust | Mus musculus | ENCSR000AIJ
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | testis |  | Permissive
      
      Robust | Mus musculus | ENCSR000CEF
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brain |  | Permissive
      
      Robust | Mus musculus | ENCSR000CEH
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | small intestine |  | Permissive
      
      Robust | Mus musculus | ENCSR000CED
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Mus musculus | ENCSR000CBY
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | limb |  | Permissive
      
      Robust | Mus musculus | ENCSR000CEB
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM12871 (male B-cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DRL
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM12878 (female B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary epithelial cells |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | skeletal muscles and myoblasts |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | normal epidermal keratinocytes |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | normal lung fibroblasts |  | Permissive
      
      Robust | Homo sapiens | GSE26320
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD4- CD8- thymocytes |  | Permissive
      
      Robust | Mus musculus | GSE41739
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | B-cells |  | Permissive
      
      Robust | Mus musculus | GSE43594
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE34094
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | trophoblast stem cells |  | Permissive
      
      Robust | Mus musculus | GSE40667
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | erythroblasts |  | Permissive
      
      Robust | Mus musculus | GSE47492
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD4+ T-cells |  | Permissive
      
      Robust | Homo sapiens | GSE12889
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HeLa (cervical adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE12889
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Jurkat (T-cells) |  | Permissive
      
      Robust | Homo sapiens | GSE12889
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cortex |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebellum |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | heart |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | kidney |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | lung |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spleen |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Bruce4 (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 brain |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 heart |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 limb |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | intestine |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | olfactory bulb |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | placenta |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | testis |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | thymus |  | Permissive
      
      Robust | Mus musculus | GSE29218
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brain |  | Permissive | Mus musculus | GSE35140
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | brain |  | Permissive
      
      Robust | Mus musculus | GSE35140
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NIH 3T3 (embryonic fibroblasts) |  | Permissive
      
      Robust | Mus musculus | GSE36048
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cell-derived neural progenitors |  | Permissive
      
      Robust | Mus musculus | GSE36203
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | PrEC (prostate cells) |  | Permissive
      
      Robust | Homo sapiens | GSE38684
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | LNCaP (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE38684
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | trophoblast stem cells |  | Permissive
      
      Robust | Mus musculus | GSE39406
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | differentiated embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE39502
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE39502
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pre-pro-B-cells |  | Permissive
      
      Robust | Mus musculus | GSE40173
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells |  | Permissive
      
      Robust | Mus musculus | GSE40173
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD4+ CD8+ thymocytes |  | Permissive
      
      Robust | Mus musculus | GSE41740
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells |  | Permissive
      
      Robust | Mus musculus | GSE41741
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | limb bud |  | Permissive | Mus musculus | GSE42237
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | B-cells |  | Permissive
      
      Robust | Mus musculus | GSE44637
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | plasmablasts |  | Permissive
      
      Robust | Mus musculus | GSE44637
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | pro-B cells |  | Permissive
      
      Robust | Mus musculus | GSE47766
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HPC7 (haematopoietic multipotent progenitors) |  | Permissive
      
      Robust | Mus musculus | GSE48085
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mast cells |  | Permissive
      
      Robust | Mus musculus | GSE48085
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE50610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE55407
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | PC3(bone mets prostate adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE57498
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | trophoblast stem cells |  | Permissive
      
      Robust | Mus musculus | GSE51610
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | BEAS-2B (bronchial epithelium) |  | Permissive
      
      Robust | Homo sapiens | GSE56051
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Mus musculus | GSE57807
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | differentiated embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE58242
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE58242
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE60232
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE60232
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | motor neurons |  | Permissive
      
      Robust | Mus musculus | GSE60232
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | motor neurons |  | Permissive
      
      Robust | Mus musculus | GSE60232
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | WEHI-231 (lymphoma ) |  | Permissive
      
      Robust | Mus musculus | GSE60917
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3134 (mammary adenocarcinoma) |  | Permissive
      
      Robust | Mus musculus | GSE61234
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 brain-derived neural progenitor cells |  | Permissive
      
      Robust | Mus musculus | GSE65748
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fibroblasts |  | Permissive
      
      Robust | Mus musculus | GSE67516
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts |  | Permissive
      
      Robust | Mus musculus | GSE69798
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic stem cells |  | Permissive
      
      Robust | Homo sapiens | GSE74967
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | macrophage-derived p20 iPS |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | macrophage-derived p3 iPS |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblast-derived p20 iPSC |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblast-derived p3 iPSC |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | neural stem cell-derived p20 iPSC |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | neural stem cell-derived p3 iPSC |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | preB-derived p20 induced pluripotent stem cells |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | preB-derived p3 induced pluripotent stem cells |  | Permissive
      
      Robust | Mus musculus | GSE76478
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HEK293 (embryonic kidney) |  | Permissive
      
      Robust | Homo sapiens | GSE76494
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | SK-OV-3 (ovarian serous cystadenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE85453
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE61475
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE61475
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE61475
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE61475
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HUES64 (embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE61475
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | OCI-LY7 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE100977
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | OCI-LY7 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE100977
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | IPSC-derived bipolar neuron |  | Permissive
      
      Robust | Homo sapiens | GSE100991
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | IPSC-derived bipolar neuron |  | Permissive
      
      Robust | Homo sapiens | GSE100991
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | DOHH2 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101017
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | DOHH2 (diffuse large B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101017
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | PC9 (lung adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101051
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | PC9 (lung adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101051
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MM1.S (plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | GSE101095
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MM1.S (plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | GSE101095
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | hepatocytes |  | Permissive
      
      Robust | Homo sapiens | GSE101103
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | hepatocytes |  | Permissive
      
      Robust | Homo sapiens | GSE101103
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | hepatocytes |  | Permissive
      
      Robust | Homo sapiens | GSE101103
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | neutrophils |  | Permissive
      
      Robust | Homo sapiens | GSE101279
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | neutrophils |  | Permissive
      
      Robust | Homo sapiens | GSE101279
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow-derived mesenchymal stromal cells |  | Permissive
      
      Robust | Mus musculus | GSE76074
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow-derived mesenchymal stromal cells |  | Permissive
      
      Robust | Mus musculus | GSE76074
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow-derived mesenchymal stromal cells |  | Permissive
      
      Robust | Mus musculus | GSE76074
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | bone marrow-derived mesenchymal stromal cells |  | Permissive
      
      Robust | Mus musculus | GSE76074
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | spermatocytes |  | Permissive
      
      Robust | Mus musculus | GSE79227
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | haploid mESCs derived from strain 129/Ola |  | Permissive
      
      Robust | Mus musculus | GSE80280
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | G1E-derived erythroid cells |  | Permissive
      
      Robust | Mus musculus | GSE80527
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | COLO-829 (melanoma) |  | Permissive
      
      Robust | Homo sapiens | GSE81945
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | RH4 (alveolar rhabdomyosarcoma) |  | Permissive
      
      Robust | Homo sapiens | GSE83726
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | hippocampus |  | Permissive | Mus musculus | GSE84174
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E10.5 forelimb |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E11.5 forelimb |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 forelimb |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E10.5 hindlimb |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E11.5 hindlimb |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E13.5 hindlimb |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E10.5 midbrain |  | Permissive
      
      Robust | Mus musculus | GSE84793
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P1 (neural progenitor cells) |  | Permissive
      
      Robust | Mus musculus | GSE85185
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14 retina |  | Permissive
      
      Robust | Homo sapiens | GSE86981
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E16 retina |  | Permissive
      
      Robust | Homo sapiens | GSE86981
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E18 retina |  | Permissive
      
      Robust | Homo sapiens | GSE86981
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E23 retina |  | Permissive
      
      Robust | Homo sapiens | GSE86981
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | retinoblastoma xenograft |  | Permissive
      
      Robust | Homo sapiens | GSE86981
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fibroblast-derived iPSCs fG140.03 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fibroblast-derived iPSCs fG140.04 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fibroblast-derived iPSCs fMG02 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | fibroblast-derived iPSCs fMG03 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Eb5 embryonic stem cells |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | immature retinal-derived iPSCs 8601 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mature retinal-derived iPSCs 3302 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mature retinal-derived iPSCs 7602 |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E17.5 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P0 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P3 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P7 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P10 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P14 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | P21 retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | retina |  | Permissive
      
      Robust | Mus musculus | GSE87037
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | U2OS (osteosarcoma) |  | Permissive
      
      Robust | Homo sapiens | GSE87831
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | JM8.N4 (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE90994
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | mammary gland |  | Permissive
      
      Robust | Mus musculus | GSE92587
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE92879
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE92879
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ECOMG-derived differentiated neutrophils |  | Permissive
      
      Robust | Mus musculus | GSE93127
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | ECOMG (myeloid progenitor cell line) |  | Permissive
      
      Robust | Mus musculus | GSE93127
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 3T3-L1-derived preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE95533
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E12.5 embryonic distal forelimb |  | Permissive
      
      Robust | Mus musculus | GSE96558
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF10A (breast epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE98551
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF10AT1 (breast premetastatic epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE98551
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF10CA1a (breast metastatic epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE98551
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE98671
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14TG2A (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE98671
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | activated primary B-cells |  | Permissive
      
      Robust | Mus musculus | GSE99195
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts |  | Permissive
      
      Robust | Mus musculus | GSE99195
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | resting primary B-cells |  | Permissive
      
      Robust | Mus musculus | GSE99195
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | primary T-cells |  | Permissive
      
      Robust | Mus musculus | GSE99195
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex |  | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex |  | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex |  | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | cerebral cortex |  | Permissive
      
      Robust | Mus musculus | GSE99363
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE25710
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Th0-cells |  | Permissive
      
      Robust | Mus musculus | GSE40918
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Th0-cells |  | Permissive
      
      Robust | Mus musculus | GSE40918
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Th17-cells |  | Permissive
      
      Robust | Mus musculus | GSE40918
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Th17-cells |  | Permissive
      
      Robust | Mus musculus | GSE40918
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | stomach |  | Permissive
      
      Robust | Mus musculus | ENCSR104QEN | MA0139.1 | 
  
    
    | CTCF | kidney |  | Permissive
      
      Robust | Mus musculus | ENCSR143WOK | MA0139.1 | 
  
    
    | CTCF | A549 (lung carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR035OXA | MA0139.1 | 
  
    
    | CTCF | lung |  | Permissive
      
      Robust | Mus musculus | ENCSR677SIH | MA0139.1 | 
  
    
    | CTCF | intestine |  | Permissive
      
      Robust | Mus musculus | ENCSR002ZAG | MA0139.1 | 
  
    
    | CTCF | hindbrain |  | Permissive
      
      Robust | Mus musculus | ENCSR150RGT | MA0139.1 | 
  
    
    | CTCF | forebrain |  | Permissive
      
      Robust | Mus musculus | ENCSR677HXC | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Mus musculus | ENCSR397RHW | MA0139.1 | 
  
    
    | CTCF | midbrain |  | Permissive
      
      Robust | Mus musculus | ENCSR985ZTV | MA0139.1 | 
  
    
    | CTCF | heart |  | Permissive
      
      Robust | Mus musculus | ENCSR491NUM | MA0139.1 | 
  
    
    | CTCF | liver |  | Permissive
      
      Robust | Mus musculus | ENCSR041SMK | MA0139.1 | 
  
    
    | CTCF | lung |  | Permissive
      
      Robust | Mus musculus | ENCSR418SBY | MA0139.1 | 
  
    
    | CTCF | HEK293 (embryonic kidney) |  | Permissive
      
      Robust | Homo sapiens | ENCSR617IFZ | MA0139.1 | 
  
    
    | CTCF | GM23338 |  | Permissive
      
      Robust | Homo sapiens | ENCSR932ZMX | MA0139.1 | 
  
    
    | CTCF | SH-SY5Y (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101295
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | SK-N-AS (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101295
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | NB69 (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE101295
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | embryonic fibroblasts |  | Permissive
      
      Robust | Mus musculus | GSE104427
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HCT-116-RAD21-mAC | N/A | Permissive
      
      Robust | Homo sapiens | GSE104888
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | CD34+ hematopoietic stem cells |  | Permissive
      
      Robust | Homo sapiens | GSE107147
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | 10 hpf embryo (bud stage) |  | Permissive
      
      Robust | Danio rerio | GSE84600
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | S2-DRSC (embryonic stem cells) |  | Permissive
      
      Robust | Drosophila melanogaster | GSE41354
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | whole organism (development stage: embryonic) |  | Permissive
      
      Robust | Drosophila melanogaster | GSE85404
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | S2 (Schneider 2) |  | Permissive
      
      Robust | Drosophila melanogaster | GSE96581
              
            
          
            
            ... | MA0531.1 | 
  
    
    | CTCF | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE115822
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | PANC1 (pancreatic ductal adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE68858
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | IMR-5 (Neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE78957
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM10847 (female B-cells Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | GSE50893
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM18486 (Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | GSE50893
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM18505 (female B-cells Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | GSE50893
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM18526 (B – cells Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | GSE50893
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM19099 (female B-cells Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | GSE50893
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | GM19193 (female B-cells Lymphoblastoid Cell Lines) |  | Permissive
      
      Robust | Homo sapiens | GSE50893
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | E14.5 limb |  | Permissive
      
      Robust | Mus musculus | GSE36027
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | Treg (regulatory T cells from lymph nodes and spleen) |  | Permissive
      
      Robust | Mus musculus | GSE36027
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | MCF7L-TamR(immortalized breast epithelial, tamoxifen resistant cell line) |  | Permissive
      
      Robust | Homo sapiens | GSE108787
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | SK-N-SH (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE115862
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HEK293T (embryonic kidney) |  | Permissive
      
      Robust | Homo sapiens | GSE115862
              
            
          
            
            ... | MA0139.1 | 
  
    
    | CTCF | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000209 | MA0139.1 | 
  
    
    | CTCF | hepatocytes |  | Permissive
      
      Robust | Homo sapiens | ERP000395 | MA0139.1 | 
  
    
    | CTCF | MCF10A (breast epithelial cells) |  | Permissive
      
      Robust | Homo sapiens | ERP000783 | MA0139.1 | 
  
    
    | CTCF | ZR-75-1 (invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000783 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | ERP002246 | MA0139.1 | 
  
    
    | CTCF | GM12878 (female B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ERP002246 | MA0139.1 | 
  
    
    | CTCF | pancreatic islets |  | Permissive
      
      Robust | Homo sapiens | ERP004003 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | ERP008568 | MA0139.1 | 
  
    
    | CTCF | HL-60 (acute myeloid leukemia) |  | Permissive
      
      Robust | Homo sapiens | ERP008568 | MA0139.1 | 
  
    
    | CTCF | U937 (adult acute monocytic leukemia) |  | Permissive | Homo sapiens | ERP008568 | MA0139.1 | 
  
    
    | CTCF | hESC-1 (Embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | GSE20650 | MA0139.1 | 
  
    
    | CTCF | hASC (preadipocytes) |  | Permissive
      
      Robust | Homo sapiens | GSE21366 | MA0139.1 | 
  
    
    | CTCF | pancreatic islets |  | Permissive
      
      Robust | Homo sapiens | GSE23784 | MA0139.1 | 
  
    
    | CTCF | BJAB (Burkitt lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE31485 | MA0139.1 | 
  
    
    | CTCF | BL41(Burkitt lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE31485 | MA0139.1 | 
  
    
    | CTCF | BCBL-1 (B-cell lymphoma) |  | Permissive
      
      Robust | Homo sapiens | GSE38411 | MA0139.1 | 
  
    
    | CTCF | VA13 (transformed lung fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE41048 | MA0139.1 | 
  
    
    | CTCF | IMR90 (lung fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE43070 | MA0139.1 | 
  
    
    | CTCF | MM1.S (plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | GSE43743 | MA0139.1 | 
  
    
    | CTCF | SUM159PT (Triple negative breast cancer) |  | Permissive
      
      Robust | Homo sapiens | GSE46055 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive
      
      Robust | Homo sapiens | GSE50893 | MA0139.1 | 
  
    
    | CTCF | erythroid cells |  | Permissive
      
      Robust | Homo sapiens | GSE67783 | MA0139.1 | 
  
    
    | CTCF |  |  | Permissive | Homo sapiens | GSE67783 | MA0139.1 | 
  
    
    | CTCF | HEK293 (embryonic kidney) |  | Permissive
      
      Robust | Homo sapiens | GSE68976 | MA0139.1 | 
  
    
    | CTCF | Jurkat (T-cells) |  | Permissive
      
      Robust | Homo sapiens | GSE68976 | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE70482 | MA0139.1 | 
  
    
    | CTCF | Delta47 (plasma cell myeloma) |  | Permissive
      
      Robust | Homo sapiens | GSE70764 | MA0139.1 | 
  
    
    | CTCF | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE70764 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE70764 | MA0139.1 | 
  
    
    | CTCF | OVCAR8 (high grade ovarian serous adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE70764 | MA0139.1 | 
  
    
    | CTCF | SK-N-SH (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | GSE76815 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | E2_SHCTCF | Permissive
      
      Robust | Homo sapiens | ERP000209 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | E2_SHCTR | Permissive
      
      Robust | Homo sapiens | ERP000209 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | TAM | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0139.1 | 
  
    
    | CTCF | GP5d (colon adenocarcinoma) | SIRAD21 | Permissive
      
      Robust | Homo sapiens | GSE51234 | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) | EMB | Permissive
      
      Robust | Homo sapiens | GSE52457 | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) | MESEN | Permissive
      
      Robust | Homo sapiens | GSE52457 | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) | MESEN_STEM | Permissive
      
      Robust | Homo sapiens | GSE52457 | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) | NEUR | Permissive
      
      Robust | Homo sapiens | GSE52457 | MA0139.1 | 
  
    
    | CTCF | WA01 (H1, human embryonic stem cells) | TROP | Permissive
      
      Robust | Homo sapiens | GSE52457 | MA0139.1 | 
  
    
    | CTCF | hESC-1 (Embryonic stem cells) | NAIVE | Permissive
      
      Robust | Homo sapiens | GSE69646 | MA0139.1 | 
  
    
    | CTCF | hESC-1 (Embryonic stem cells) | PRIMED | Permissive
      
      Robust | Homo sapiens | GSE69646 | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) | 2D3 | Permissive
      
      Robust | Homo sapiens | GSE69962 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | HYPOXIA | Permissive
      
      Robust | Homo sapiens | GSE78113 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) | NORMOXIA | Permissive
      
      Robust | Homo sapiens | GSE78113 | MA0139.1 | 
  
    
    | CTCF | VCaP (prostate carcinoma) | ETOH | Permissive
      
      Robust | Homo sapiens | GSE84432 | MA0139.1 | 
  
    
    | CTCF | VCaP (prostate carcinoma) | R1881 | Permissive
      
      Robust | Homo sapiens | GSE84432 | MA0139.1 | 
  
    
    | CTCF | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ERP000380 | MA0139.1 | 
  
    
    | CTCF | GP5d (colon adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE51234 | MA0139.1 | 
  
    
    | CTCF | THP-1 (acute monocytic leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE69962 | MA0139.1 |